Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetil

Experimental and Clinical Transplantation

Volumn 4, Issue 2, 2006, Pages 532-536

  Kamar, Nassim ^a   Van, Tuan Tran ^a   Ribes, David ^a   Modesto, Anne ^a   Cointault, Olivier ^a   Lavayssière, Laurence ^a   Ader, Jean Louis ^a   Durand, Dominique ^a   Rostaing, Lionel ^a  

^a CHU RANGUEIL   (France)

Author keywords

Histology; Inulin clearance; Mycophenolate mofetil; Renal functional reserve; Sirolimus

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ASPARTATE AMINOTRANSFERASE; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TRIACYLGLYCEROL; VALACICLOVIR; CREATININE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ACUTE GRAFT REJECTION; ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBROSING ALVEOLITIS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTERSTITIUM; INULIN CLEARANCE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LEUKOCYTE; LONG TERM CARE; LYMPHOCYTE; MALE; MICROALBUMINURIA; MONONUCLEAR CELL; NEUTROPHIL; PNEUMOCYSTOSIS; POSTOPERATIVE PERIOD; SIDE EFFECT; THROMBOCYTE; VIREMIA; ALLOTRANSPLANTATION; BIOPSY; BLOOD; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; BIOPSY; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; SIROLIMUS; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33847746602     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Vitko S, Wlodarczyk Z, Kyllönen L, Czajkowski Z, Margreiter R, Backman L, et al. Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: Results of a multicenter study. Am J Transplant 2006; 6: 531-538
2. Ciancio G, Burke GW, Gaynor PR, Roth D, Kupin W, Rosen A, et al. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/ mycophenolate versus cycloporine/sirolimus in renal transplantation: three-year analysis. Transplantation 2006; 81: 845-852
3. Meier-Kriesche HU, Steffen BJ, Hochberg AM, Gordon RD, Liebman MN, Morris JA, et al. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation 2003; 75: 1341-1346
4. Merville P, Berge F, Deminiere C, Morel D, Chong G, Durand D, et al. Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil. Am J Transplant 2004; 4: 1769-1775
5. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman AB, Cibrik D, Magee JC, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000; 69: 2405-2409
6. Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, et al. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 2005; 16: 3755-3762
7. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 2273-2280
8. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
9. Flechner SM, Kurian SM, Solez K, Cook DJ, Burke JT, Rollin H, et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 1776-1785
10. Podder H, Stepkowski SM, Napoli KL, Clark J, Verani RR, Chou TC, et al. Pharmacokinetic interactions augment toxicities of sirolimus/ cyclosporine combinations. J Am Soc Nephrol 2001; 12: 1059-1071
11. Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 2004; 4: 953-961